reading 503A threads from 2024 and half of it aged badly
Something I keep coming back to: reading 503A threads from 2024 and half of it aged badly. The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes. Potency and sterility testing on the finished preparation are separate…
Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.
Careful. Naming a clinic without describing what actually happened turns this into a different kind of thread.
Careful.
hassan_chowdhury is right about the concentration trap. It breaks arithmetic that has been reliable for months.
hassan_chowdhury is right about the concentration trap.
Adding one thing — ask for the facility name. Most will give it, and the ones that will not have answered you.
Yes — asking which facility, by name, is the single most useful question and most clinics will answer it.
The intake asked me three questions and none of them were about my history. That told me everything I needed to know about the model.
the label on a compounded vial is a legal document, read it
ask which facility, then ask for their testing
a telehealth intake that asks nothing has told you what it is
Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.
do not assume the concentration matches the branded product